VPAResearch

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.


Research Reports By VPAResearch

Found 1346 publications
Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 65 pages
Yellow Fever Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 40 pages
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 45 pages
Herpes Labialis Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 35 pages
Rotavirus Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 45 pages
Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 30 pages
Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 90 pages
Vancomycin Resistant Enterococcal (VRE) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 70 pages
Aspergillosis Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 90 pages
Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 50 pages
Rabies Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 60 pages
Chlamydia Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 60 pages
Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 90 pages
Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 35 pages
Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 35 pages
Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 30 pages
Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 90 pages
Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 40 pages
Tetanus Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 65 pages
Haemophilus influenza (Hib)- Type B Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 60 pages
Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 35 pages
Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 70 pages
Human Parainfluenza Virus 3 (HPIV-3) Infection Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 30 pages
Rubella (German measles) Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 30 pages
Diphtheria Drug Development Pipeline Study, H2 2018 US$ 1,200.00 Aug, 2018 60 pages
2018 and Beyond: Norway Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Sweden Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Cyprus Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: France Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Lithuania Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Russia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Belgium Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Iceland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: New Zealand Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Spain Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Croatia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Finland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Latvia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Romania Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Austria Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Hungary Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Netherlands Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: South Korea Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Chile Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: United Kingdom Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Estonia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Japan Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Portugal Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Australia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
2018 and Beyond: Greece Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 US$ 2,000.00 Jul, 2018 120 pages
1 2 3 4 5 ... 27
Skip to top